RHEACELL

Stem cell company manufacturing GMP-compliant limbal stem cells from cornea tissue that are ABCB5+, a marker associated with clinical success in transplantation of these cells for treating blindness.

Overview Structured Data Issues Contributors

rheacell.com

Is a

Organization

Company

Company attributes

Industry

Stem cell

Healthcare

MSC (Mesenchymal Stromal Cell)

Location

B2X

CEO

Founder

Pitchbook URL

pitchbook.com/profiles...438195-61

Date Incorporated

2012

Number of Employees (Ranges)

51 – 2000

Email Address

office@rheacell.com0

Phone Number

+4962217183300

Full Address

Im Neuenheimer Feld 517 69120 Heidelberg, Germany0

Founded Date

2003

Country

Germany

Other attributes

Company Operating Status

Active

RHEACEL is a subsidiary of TICEBA, developing human pharmaceuticals based on ABCB5+ mesenchymal stem cells. The company uses the GMP-compliant manufacturing process established by TICEBA to expand primary limbal stem cells from corneal tissue donors. Clinical trials using these cells are ongoing in Germany and the US.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like RHEACELL

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.